Serum response factor indirectly regulates type i interferon-signaling in macrophages

Journal of Interferon and Cytokine Research

Volumn 33, Issue 10, 2013, Pages 588-596

  Xie, Lan ^a,b,c   Sullivan, Amy L ^b   Collier, Jana G ^b   Glass, Christopher K ^b  

^a Tsinghua University   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL ENGINEERING RESEARCH CENTER FOR BEIJING BIOCHIP TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DACTINOMYCIN; INTERFERON; INTERFERON STIMULATED GENE FACTOR; INTERFERON STIMULATED GENE FACTOR 3; JANUS KINASE; LIPOPOLYSACCHARIDE; POLYINOSINIC POLYCYTIDYLIC ACID; SERUM RESPONSE FACTOR; STAT PROTEIN; STAT1 PROTEIN; STAT2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUNCTION; CONTROLLED STUDY; DRUG MECHANISM; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; INNATE IMMUNITY; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BINDING SITES; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; INFLAMMATION; INTERFERON REGULATORY FACTORS; INTERFERON TYPE I; INTERFERON-BETA; INTERFERON-STIMULATED GENE FACTOR 3; JANUS KINASES; MACROPHAGES; MALE; MICE; NUCLEOTIDE MOTIFS; POSITION-SPECIFIC SCORING MATRICES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RNA STABILITY; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84885662077     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0065     Document Type: Article

References (33)

1. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4(7):499-511. (Pubitemid 38931765)
2. Alberti S, Krause SM, Kretz O, Philippar U, Lemberger T, Casanova E, Wiebel FF, Schwarz H, Frotscher M, Schutz G, Nordheim A. 2005. Neuronal migration in the murine rostral migratory stream requires serum response factor. Proc Natl Acad Sci USA 102(17):6148-6153. (Pubitemid 40594270)
3. Barton GM, Medzhitov R. 2003. Toll-like receptor signaling pathways. Science 300(5625):1524-1525. (Pubitemid 36682871)
4. Cen B, Selvaraj A, Burgess RC, Hitzler JK, Ma Z, Morris SW, Prywes R. 2003. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol 23(18):6597-6608. (Pubitemid 37075770)
5. Chai J, Tarnawski AS. 2002. Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol 53(2):147-157. (Pubitemid 34717237)
6. Coccia EM, Uze G, Pellegrini S. 2006. Negative regulation of type I interferon signaling: facts and mechanisms. Cell Mol Biol (Noisy-le-grand) 52(1):77-87. (Pubitemid 43925164)
7. Fleige A, Alberti S, Grobe L, Frischmann U, Geffers R, Muller W, Nordheim A, Schippers A. 2007. Serum response factor contributes selectively to lymphocyte development. J Biol Chem 282(33):24320-24328. (Pubitemid 47328050)
8. Gale M, Jr., Foy EM. 2005. Evasion of intracellular host defence by hepatitis C virus. Nature 436(7053):939-945. (Pubitemid 41191669)
9. Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, Willson TM, Rosenfeld MG, Glass CK. 2007. Parallel SUMOylationdependent pathways mediate gene-and signal-specific transrepression by LXRs and PPARgamma. Mol Cell 25(1):57-70. (Pubitemid 46049061)
10. Goodridge HS, Harnett MM. 2005. Introduction to immune cell signalling. Parasitology 130 (Suppl):S3-S9. (Pubitemid 41626587)
11. Guha M, O'Connell MA, Pawlinski R, Hollis A, McGovern P, Yan SF, Stern D, Mackman N. 2001. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98(5):1429-1439.
12. Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW, Ching KA, Antosiewicz-Bourget JE, Liu H, Zhang X, Green RD, Lobanenkov VV, Stewart R, Thomson JA, Crawford GE, Kellis M, Ren B. 2009. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459(7243): 108-112.
13. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38(4):576-589.
14. Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6(9):644-658. (Pubitemid 44298214)
15. Impey S, Fong AL, Wang Y, Cardinaux JR, Fass DM, Obrietan K, Wayman GA, Storm DR, Soderling TR, Goodman RH. 2002. Phosphorylation of CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron 34(2):235-244. (Pubitemid 34442566)
16. Karumuthil-Melethil S, Perez N, Li R, Vasu C. 2008. Induction of innate immune response through TLR2 and dectin 1 prevents type 1 diabetes. J Immunol 181(12):8323-8334.
17. Lahoute C, Sotiropoulos A, Favier M, Guillet-Deniau I, Charvet C, Ferry A, Butler-Browne G, Metzger D, Tuil D, Daegelen D. 2008. Premature aging in skeletal muscle lacking serum response factor. PLoS One 3(12):e3910.
18. Lehtonen A, Matikainen S, Julkunen I. 1997. Interferons upregulate STAT1, STAT2, and IRF family transcription factor gene expression in human peripheral blood mononuclear cells and macrophages. J Immunol 159(2):794-803. (Pubitemid 127484231)
19. Levy DE, Kessler DS, Pine R, Reich N, Darnell JE, Jr. 1988. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev 2(4):383-393.
20. Li Q, Verma IM. 2002. NF-kappaB regulation in the immune system. Nat Rev Immunol 2(10):725-734.
21. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402-408. (Pubitemid 34164012)
22. Miano JM. 2003. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 35(6):577-593. (Pubitemid 36681543)
23. Miano JM, Long X, Fujiwara K. 2007. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol 292(1):C70-C81. (Pubitemid 46115122)
24. Miano JM, Ramanan N, Georger MA, de Mesy Bentley KL, Emerson RL, Balza RO, Jr., Xiao Q, Weiler H, Ginty DD, Misra RP. 2004. Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci USA 101(49):17132-17137. (Pubitemid 39627786)
25. Panne D, Maniatis T, Harrison SC. 2004. Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer. EMBO J 23(22):4384-4393. (Pubitemid 39601963)
26. Schratt G, Philippar U, Berger J, Schwarz H, Heidenreich O, Nordheim A. 2002. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells. J Cell Biol 156(4):737-750. (Pubitemid 34839888)
27. Sullivan AL, Benner C, Heinz S, HuangW, Xie L, Miano JM, Glass CK. 2010. Serum response factor utilizes distinct promoter-and enhancer-based mechanisms to regulate cytoskeletal gene expression in macrophages. Mol Cell Biol 31(4):861-875.
28. Sun K, Battle MA, Misra RP, Duncan SA. 2009. Hepatocyte expression of serum response factor is essential for liver function, hepatocyte proliferation and survival, and postnatal body growth in mice. Hepatology 49(5):1645-1654.
29. Sun Q, Chen G, Streb JW, Long X, Yang Y, Stoeckert CJ, Jr., Miano JM. 2006. Defining the mammalian CArGome. Genome Res 16(2):197-207. (Pubitemid 43200268)
30. Takaoka A, Yanai H. 2006. Interferon signalling network in innate defence. Cell Microbiol 8(6):907-922. (Pubitemid 43670834)
31. Treisman R. 1986. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell 46(4):567-574. (Pubitemid 16022411)
32. Wesoly J, Szweykowska-Kulinska Z, Bluyssen HA. 2007. STAT activation and differential complex formation dictate selectivity of interferon responses. Acta Biochim Pol 54(1): 27-38. (Pubitemid 46481813)
33. Yadav M, Schorey JS. 2006. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 108(9):3168-3175.